These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32187786)
21. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients. Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352 [TBL] [Abstract][Full Text] [Related]
22. [Platelet antigens and antibodies against them]. Zotikov EA Biull Eksp Biol Med; 2000 Mar; 129(3):244-7. PubMed ID: 10776555 [No Abstract] [Full Text] [Related]
23. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related]
24. Use of single donor platelets. Kirkley SA; Blumberg N Blood Rev; 1994 Sep; 8(3):142-7. PubMed ID: 7819816 [TBL] [Abstract][Full Text] [Related]
25. [Prevention of HLA-alloimmunization of recipients of platelet concentrates]. Kuntz BM; Wollenhaupt HJ; BrĂ¼ster HT Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621 [TBL] [Abstract][Full Text] [Related]
27. [Effect of HPA-1a(PLA1) and HLA antibodies on platelet function, measured with the in vitro bleeding test]. Kretschmer V; Huss B; Feller K; Kiefel V Beitr Infusionsther Transfusionsmed; 1994; 32():221-4. PubMed ID: 9480093 [TBL] [Abstract][Full Text] [Related]
28. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization. Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466 [No Abstract] [Full Text] [Related]
29. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758 [TBL] [Abstract][Full Text] [Related]
30. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy. Brubaker DB; Romine M Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931 [TBL] [Abstract][Full Text] [Related]
31. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched. Rubinstein P Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628 [No Abstract] [Full Text] [Related]
32. [Platelet transfusions, refractory states, contribution of laboratories]. Kaplan C Ann Med Interne (Paris); 1994; 145(5):350-1. PubMed ID: 7985947 [No Abstract] [Full Text] [Related]
33. Review and update of platelet alloantigen systems. Mueller-Eckhardt C; Kiefel V; Santoso S Transfus Med Rev; 1990 Apr; 4(2):98-109. PubMed ID: 2134627 [No Abstract] [Full Text] [Related]
34. Finding platelets: Don't let the perfect be the enemy of the good. Brunker PAR; Pattanayak V; Mahowald GK Transfusion; 2021 Aug; 61(8):2223-2228. PubMed ID: 34365668 [No Abstract] [Full Text] [Related]
35. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions. Sandler SG Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252 [TBL] [Abstract][Full Text] [Related]